Profile picture

Doctor Masaki Shimizu

Sapporo Medical University, Sapporo (Japan)
Follow
Logo ESC

Contributor content

Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis
Presentation
Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis
Read more
Nuclear accumulation of MLKL induces necroptosis in cardiomyocytes: potential implication in Doxorubicin-induced cardiotoxicity.
Presentation
Nuclear accumulation of MLKL induces necroptosis in cardiomyocytes: potential implication in Doxorubicin-induced cardiotoxicity.
Read more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources